The People's Vaccine Alliance

News

With US government supplies of Covid vaccines predicted to run out in the first quarter of 2023, it has been revealed that Pfizer/BioNTech

News

Arrowhead Pharma is squaring up to rival Ionis in the severe hypertriglyceridaemia (sHTG) market, drawing on phase 3 data at ESC 2026.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.